BMRN — BioMarin Pharmaceutical Inc
In 2026 Q2, 6 of the 140 tracked hedge funds reported a position in BioMarin Pharmaceutical Inc (BMRN), worth $59.94M combined. Over the quarter 5 opened or added, 4 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $25.86M | 0.04% | -55.9% |
| VanEck | $17.57M | 0.01% | +68.8% |
| Monaco | $10.58M | 3.90% | +516.5% |
| Persistent | $4.57M | 1.40% | +113.3% |
| Quadrature | $816.87K | 0.00% | +50.4% |
| IMC | $541.70K | 0.00% | +69.1% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.